Abstract
In this study, twenty-five new 6-methyl-4,5-dihydropyridazin-3(2H)-one derivatives having N-acylhydrazone and thiosemicarbazide moieties were synthesized. The target compounds were tested for their antimycobacterial activity in vitro against Mycobacterium tuberculosis H37Rv using the agar dilution method. Among the synthesized compounds, N′-(2,4-dichlorobenzylidene)-2-(3-methyl-6-oxo-5,6-dihydropyridazin-1(4H)-yl)acetohydrazide 4g was found to be the most active compound with minimum inhibitory concentration of 0.78 μM and was more potent than ethambutol and ciprofloxacin.
Similar content being viewed by others
References
Abdel-Aziz M, Abdel-Rahman HM (2010) Synthesis and anti-mycobacterial evaluation of some pyrazine-2-carboxylic acid hydrazide derivatives. Eur J Med Chem 45(8):3384–3388
Bukowski L, Janowiec M (1996) 1-Methyl-1H–2-imidazo[4, 5-b]pyridinecarboxylic acid and some of its derivatives with suspected antituberculotic activity. Pharmazie 51(1):27–30
Cardia MC, Distinto S, Maccioni E, Plumitallo A, Saddi M, Sanna ML (2006) Isonicotinoylhydrazothiazoles and isonicotinoyl-N4-substituted thiosemicarbazides: synthesis, characterization, and anti-mycobacterial activity. J Heterocycl Chem 43(5):1337–1347
Dye C (2006) Global epidemiology of tuberculosis. Lancet 367(9514):938–940
Islam M, Siddiqui AA, Rajesh R (2008) Synthesis, antitubercular, antifungal and antibacterial activities of 6-substituted phenyl-2-(3′-substituted phenyl pyridazin-6′-yl)-2,3,4,5-tetrahydropyridazin-3-one. Acta Pol Pharm 65(3):353–362
Janin YL (2007) Antituberculosis drugs: ten years of research. Bioorg Med Chem 15(7):2479–2513
Mamolo MG, Falagiani V, Zampieri D, Vio L, Banfi E (2001) Synthesis and antimycobacterial activity of [5-(pyridin-2-yl)-1,3,4-thiadiazol-2-ylthio]acetic acid arylidene-hydrazide derivatives. Farmaco 56(8):587–592
Mantu D, Luca MC, Moldoveanu C, Zbancioc G, Mangalagiu II (2010) Synthesis and antituberculosis activity of some new pyridazine derivatives. Part II. Eur J Med Chem 45(11):5164–5168
National Committee for Clinical Laboratory Standards (1995) Antimycobacterial susceptibility testing for Mycobacterium tuberculosis. Proposed standard M24-T. National Committee for Clinical Laboratory Standards, Villanova
Nayyar A, Monga V, Malde A, Coutinho E, Jain R (2007) Synthesis, anti-tuberculosis activity, and 3D-QSAR study of 4-(adamantan-1-yl)-2-substituted quinolines. Bioorg Med Chem 15(2):626–640
Palla G, Predieri G, Domiano P, Vignali C, Turner W (1986) Conformational behavior and E/Z isomerization of N-acyl and N-aroylhydrazones. Tetrahedron 42(13):3649–3654
Reichelt I, Reissig HU (1984) Eine einfache und flexible Synthese für 4,5-Dihydro-2H-3-pridazinone. Synthesis-Stuttgart 9:786–787
Scifinder CAS RN 1065104-31-5 and RN 1065104-32-6. https://scifinder.cas.org
Syakaev VV, Podyachev SN, Buzykin BI, Latypov SK, Habicher WD, Konovalov AI (2006) NMR study of conformation and isomerization of aryl- and heteroarylaldehyde 4-tert-butylphenoxyacetylhydrazones. J Mol Struct 788(1–3):55–62
Ulusoy N, Gursoy A, Otuk G (2001) Synthesis and antimicrobial activity of some 1,2,4-triazole-3-mercaptoacetic acid derivatives. Farmaco 56(12):947–952
Unsal-Tan O, Ozden K, Rauk A, Balkan A (2010) Synthesis and cyclooxygenase inhibitory activities of some N-acylhydrazone derivatives of isoxazolo[4,5-d]pyridazin-4(5H)-ones. Eur J Med Chem 45(6):2345–2352
Acknowledgments
The authors thank the financial support provided by Scientific Research Fund of Hacettepe University through Project 0801301003. The authors also thank Assoc. Prof Dr. Aymil Dogan (Faculty of Letters, Translation and Interpretation Department, Hacettepe University) for grammatical revision.
Conflict of interests
The authors report no declarations of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Unsal Tan, O., Ozadali, K., Yogeeswari, P. et al. Synthesis and antimycobacterial activities of some new N-acylhydrazone and thiosemicarbazide derivatives of 6-methyl-4,5-dihydropyridazin-3(2H)-one. Med Chem Res 21, 2388–2394 (2012). https://doi.org/10.1007/s00044-011-9770-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-011-9770-6